First drug to demonstrate therapeutic effect in a type of autism identified

Washington, May 20 (ANI): American researchers have identified a drug that improves communication between nerve cells in a mouse model of Phelan-McDermid Syndrome (PMS).

Previous research has shown that a gene mutation in the brain called SHANK3 can cause absent or severely delayed language abilities, intellectual disability, and autism.

Researchers at Mount Sinai School of Medicine developed mice with a mutant SHANK3 gene and observed a lapse in communication between nerve cells in the brain, which can lead to learning problems. This communication breakdown indicated that the nerve cells were not maturing properly.

The scientists then injected the mice with a derivative of a compound called insulin-like growth factor-1 (IGF1), which is FDA-approved to treat growth failure in children.

After two weeks of treatment, nerve cell communication was normal and adaptation of nerve cells to stimulation, a key part of learning and memory, was restored.

Joseph Buxbaum, Director of the Seaver Autism Center for Research and Treatment at Mount Sinai School of Medicine, said: “The result of IGF1 treatment of these mice is an exciting development on the road to ultimate therapies for individuals with PMS.

“If these data are further verified in additional preclinical studies, individuals with a SHANK3 mutation may benefit from treatments with compounds like this one.” (ANI)

Mechanism that prepares newborn’s brain for information processing found

Washington, May 15 (ANI): A mechanism in the memory centre of newborn that adjusts the maturation of the brain for the information processing required later in life has been found by researchers at the University of Helsinki.

The study was published this week in an American science magazine The Journal of Neuroscience.

The brain cells in the brain of a newborn are still quite loosely interconnected. In the middle of chaos, they are looking for contact with each other and are only later able to operate as interactive neural networks.

Many cognitive operations, such as attention, memory, learning and certain states of sleep are based on rhythmic interactions of neural networks. For a long time the researchers have been interested in finding the stage in the development of the brain in which the functional characteristics and interconnections are sufficiently developed for these subtle brain functions.

Key players in this maturation process include a type of nerve cells called interneurones, and recent research sheds light on their functional development. The researchers have noticed that the activeness of the interneurones change dramatically during early development. In the memory centre of the brain they found a mechanism which adjusts changes in the activeness of interneurones.

The interneurones nerve cells are kind of controller cells. In the nervous system of a newborn they promote the creation of nerve cell contacts, and on the other hand they prevent premature rhythmic activity of neural networks. During development the controlling role will change, and the result is that the neural network becomes more efficiently rhythmic. This can be seen, for example, in the strengthening of the EEG signal during sleep.

The mechanism adjusting the activity of the interneurones is related to the development phase which prepares the brain to process and handle information needed later in life. The finding may also offer more detailed means to intervene in the electric disorders of developing neural networks, such as epilepsy. (ANI)

Stem cells have GPS to generate proper nerve cells

Washington, May 12 (ANI): Swedish researchers have discovered an unknown GPS function that regulates how stem cells produce different types of cells in different parts of the nervous system.

The discovery by Stefan Thor, professor of Developmental Biology, and graduate students Daniel Karlsson and Magnus Baumgardt, at Linköping University in Sweden, could improve our understanding of how stem cells work, which is crucial for our ability to use stem cells to treat and repair organs.

Stem cells are responsible for the creation of all cells in an organism during development.

Previous research has shown that stem cells give rise to different types of cells in different parts of the nervous system.

This process is partly regulated by the so-called Hox genes, which are active in various parts of the body and work to give each piece its unique regional identity – a kind of GPS system of the body.

But the researchers don’t know how does a stem cell know that it is in a certain region and how does it read the body”s “GPS” signals.

The scientists also wanted to find out how this information is used to control the creation of specific nerve cells.

Thus, the researchers studied a specific stem cell in the nervous system of the fruit fly.

It is present in all segments of the nervous system, but it is only in the thorax, or chest region, that it produces a certain type of nerve cell.

To investigate why this cell type is not created in the stomach or head region they manipulated the Hox genes” activity in the fly embryo.

It turned out that the Hox genes in the stomach region stop stem cells from splitting before the specific cells are produced.

On the other hand, the specific nerve cells are actually produced in the head region, but the Hox genes turn them into another, unknown, type of cell.

Hox genes can thus exert their influence both on the genes that control stem cell division behaviour and on the genes that control the type of nerve cells that are created.

“We constantly find new regulating mechanisms, and it is probably more difficult than previously thought to routinely use stem cells in treating diseases and repairing organs, especially in the nervous system”, said Thor.

The findings are publishing in the online, open-access journal PLoS Biology. (ANI)

Endometrial stem cells could repair Parkinson”s related brain cell damage

Washington, May 7 (ANI): In a study on mice, researchers found that stem cells derived from the endometrium (uterine lining) could repair brain cells damaged by Parkinson”s disease, according to Yale School of Medicine researchers.

Although these are preliminary results, the findings increase the likelihood that endometrial tissue could be harvested from women with Parkinson”s disease and used to re-grow brain areas that have been damaged by the disease, according to lead author Dr. Hugh S. Taylor.

Because of their ability to divide into new cell types, stem cells could be the key to treating many different kinds of diseases, like Parkinson”s, in which the body”s own cells are damaged or depleted.

Parkinson”s is caused by a breakdown of dopamine-producing nerve cells in the brain stem. Dopamine is a neurotransmitter that stimulates the motor neurons that in turn control muscles.

When dopamine production is reduced, the nerves fail to control movement or maintain coordination.

In their study, the researchers collected and cultured endometrial tissue from nine women, and verified that they could be transformed into dopamine-producing nerve cells like those in the brain.

“The dopamine levels in the mice increased once we transferred the endometrial stem cells into their brains. This is encouraging because women have a ready supply of stem cells that are easily obtained, can differentiate into other cell types. They may have great potential for treating multiple diseases,” said Taylor.

Highlighting the benefits of using endometrial stem cells, Taylor said the ethical concerns surrounding the use of embryonic stem cells are eliminated when using adult stem cells.

Taylor also pointed out that endometrial stem cells are one of the best sources for generating neurons because they appear to be less likely to be rejected than stem cells from other sources.

“This is just the tip of the iceberg of what we will be able to do with these cells. We believe these neurons are only the first of many cell types derived from endometrium that will be used to treat a variety of diseases,” said Taylor.

The findings are published in the Journal of Cellular and Molecular Medicine. (ANI)

Genetic study sheds light on chronic pain

Washington, May 7 (ANI): Chronic pain, which often occurs without an apparent cause, may be caused by the inadvertent reprogramming of more than 2,000 genes in the peripheral nervous system, suggests new research.

Mayo Clinic researchers think that the finding could ultimately lead to ‘transcription therapy’, which would employ drugs that kill pain by correcting the activity of specific genes.

The researchers focused on nerve cells suspected to be involved in pain: dorsal root ganglion neurons of the peripheral nervous system in rodent models. They performed high-throughput sequencing of hundreds of millions of mRNA molecules, the messengers of gene activity.

Powerful computer science was required to sort through the many pieces of information (50 base-pair long mRNA sequence “reads”) assembling the complicated genomic puzzle.

The resulting picture revealed a number of surprises, among them 10,464 novel exons (sections of the genome involved in creating proteins) and some 400 gene candidates described for the first time in the study.

Furthermore, detailed building plans for thousands of spliced mRNA were mapped.

“Using this new approach offers greater sensitivity, dynamic range and more efficient unbiased genetic mapping compared to the previous microarray-based methods and may be an efficient new approach to a wide array of problems in neuroscience research,” says Andreas Beutler, Mayo Clinic oncologist and co-author on the study.

The findings appear in the current issue of the journal Genome Research. (ANI)

”Hair of the dog” may help cure hangover, but increase alcohol dependency

Washington, May 6 (ANI): Neuroscientists from the University of Southampton”s School of Biological Sciences claim that the “hair of the dog” may cure a hangover but it can also increase alcohol dependency.

Drinking alcohol over a long period of time profoundly affects the brain, which adapts to the intoxicant and causes withdrawal symptoms when consumption stops.

Now, the study boffins investigated alcohol dependency and withdrawal using tiny 1mm long C. elegans worms. Despite the worm”s evolutionary distance from humans, and very simple brain of just 302 nerve cells, it exhibits similar alcohol-dependent behaviours.

The research showed that withdrawal symptoms could be relieved by small doses of alcohol. However, easing the effects can increase dependency.

In humans, the symptoms are manifested in anxiety, agitation and, in extreme cases, seizures. The worms, as video footage shows, also became overactive in alcohol withdrawal and showed spontaneous and deep body bends – a behaviour rarely seen in ”teetotal” worms.

Professor Lindy Holden-Dye, a neuroscientist of the University”s School of Biological Sciences and member of Southampton Neurosciences Group (SoNG), led the study. She comments: “This research showed the worms displaying effects of the withdrawal of alcohol and enables us to define how alcohol affects signalling in nerve circuits which leads to changes in behaviour.”

The study, published in the journal PLoS ONE, also showed evidence that a particular class of brain-signalling molecule, the neuropeptide, is required for the chronic effect of alcohol on the worm”s nervous system.

Professor Holden-Dye adds: “Neuropeptides are also involved in chronic alcohol effects in humans and this is leading to new ideas for the treatment of alcoholism, but their precise role is unclear. Our study provides a very effective experimental system to tackle this problem.” (ANI)

Dark chocolate may provide protection against brain injury from stroke

Washington, May 6 (ANI): A compound in dark chocolate may protect the brain after a stroke by increasing cellular signals already known to shield nerve cells from damage, Johns Hopkins researchers have discovered.

Ninety minutes after feeding mice a single modest dose of epicatechin, a compound found naturally in dark chocolate, the scientists induced an ischemic stroke by essentially cutting off blood supply to the animals” brains.

They found that the animals that had preventively ingested the epicatechin suffered significantly less brain damage than the ones that had not been given the compound.

While most treatments against stroke in humans have to be given within a two- to three-hour time window to be effective, epicatechin appeared to limit further neuronal damage when given to mice 3.5 hours after a stroke. Given six hours after a stroke, however, the compound offered no protection to brain cells.

Sylvain Doré, Ph.D., associate professor of anesthesiology and critical care medicine and pharmacology and molecular sciences at the Johns Hopkins University School of Medicine, says his study suggests that epicatechin stimulates two previously well-established pathways known to shield nerve cells in the brain from damage.

When the stroke hits, the brain is ready to protect itself because these pathways — Nrf2 and heme oxygenase 1 — are activated. In mice that selectively lacked activity in those pathways, the study found, epicatechin had no significant protective effect and their brain cells died after a stroke.

The study appears online in the Journal of Cerebral Blood Flow and Metabolism. (ANI)

Groundbreaking new understanding of stem cells

London, May 3 (ANI): Researchers from The Scripps Research Institute have detailed some striking differences between the biochemistry of stem cells versus mature cells—a feat that could one day lead to new therapies.

Led by Gary Siuzdak, the researchers used a unique approach to better understand stem cells, which have the ability to change or “differentiate” into adult cell types (such as hair cells, skin cells, nerve cells).

Understanding how stem cells mature opens the door for scientists and physicians to manipulate the process to meet the needs of patients, potentially treating such intractable conditions as Parkinson”s disease and spinal injury.

“In the past, scientists trying to understand stem cell biology focused on genes and proteins. In our study, we looked at stem cell regulation in a different way—on the biochemical level, on a functional level. With metabolomics profiling, we were able to look at naturally occurring small molecules and how they control cell fate on a completely different level,” Nature quoted Ding as saying.

The new paper describes parts of the stem cell “metabolome”— the complete set of substances (“metabolites”) formed in metabolism, including all naturally occurring small molecules, biofluids, and tissues.

The scientists then compared this profile to those of more mature cells, specifically of nerve cells and heart cells.

After tallying the results, the scientists had found about 60 previously unidentified metabolites associated with the progression of stem cells to mature cells, as well as an unexpected pattern in the chemistry that mirrored the cells” increasing biological maturity.

The study of metabolomics is relatively new, having emerged only over the past decade or so.

“One of the most interesting aspects of metabolomics is how little we know. We don”t know what the vast majority of metabolites are, or what they do. It is an area ripe for discovery,” commented Siuzdak.

In the current study, the team used liquid chromatography-mass spectrometry (LCMS), which draws on two more traditional techniques to provide scientists with the ability to chemically analyse virtually any molecular species.

The group then analysed the resulting data using an open-access bioinformatics platform XCMS.

The XCMS software allows researchers to identify and assess metabolite and peptide features that show significant change between sample groups—in this case mouse stem cells versus mature cells.

The most difficult part of untargeted metabolomics studies is analysing the results and characterizing metabolites, said Oscar Yanes, the new paper”s first author.

Still, Yanes shifted though the data on stem cells and identified an unexpected pattern— stem cell metabolites had highly unsaturated structures compared with mature cells, and levels of highly unsaturated molecules decreased as the stem cells matured.

Highly unsaturated molecules, which contain little hydrogen, can easily react and change into many other different types of molecules.

“The study reveals an astounding cellular strategy. The capacity of embryonic stem cells to generate a whole spectrum of cell types characteristic of different tissues (a phenomenon referred to as plasticity) is mirrored at the metabolic level,” said Yanes.

“We were not expecting these results. Although in retrospect it makes sense that stem cells (which can form almost any cell) have metabolites that are chemically flexible,” said Siuzdak.

The study was published in an advance, online edition of the prestigious journal Nature Chemical Biology. (ANI)

Neuroscientists verify how nerve cells distinguish odours

Washington, Apr 29 (ANI): Mice in which a certain receptor in the olfactory centre is missing can distinguish similar smells more quickly than mice without genetic manipulation, showed a new study.

The researchers in Professor Dr. Thomas Kuner’s team at the Institute of Anatomy and Cell Biology at Heidelberg University Medical School and Dr. Andreas Schäfer at the Max Planck Institute for Medical Research directly attributed the above behaviour to inhibitor loops between adjacent nerve cells.

The Heidelberg researchers have for the first time confirmed “lateral inhibition” for the olfactory system, from the molecular level to behaviour.

Odours attach to receptors of olfactory cells in nasal mucosa, where they trigger nerve signals.

These signals are processed in what is known as the olfactory bulb, a part of the brain.

In the neuronal network, the incoming signal is converted to a specific electrical pattern that is transmitted to the cerebral cortex and other areas of the brain and is recognized there.

The researchers have now shown for the first time how neuronal processing of olfactory stimuli directly affects the behaviour of test animals.

“We manipulated information processing very specifically in the olfactory bulb and then measured the effect of this genetic manipulation based on reaction time. We were thus able to prove that the test animals, due to localized inhibitor loops, could distinguish very similar odor combinations much faster, yet very reliably,” explained Kuner.

Inhibition via interneurons acts as a kind of filter by amplifying strong stimuli and further weakening weak stimuli, which makes the essential information easier to recognize.

In the test animals, reaction time was reduced by about 50 ms. The time needed by test animals to learn various odors and their memory capability remained unaffected. Recognition of simple odors was also unchanged.

The results of the study were published in the prestigious journal ‘Neuron’. (ANI)

Cochlear implantation in kids linked to improved language skills

Washington, April 21 (ANI): Children with hearing loss can benefit immensely if they receive a cochlear implant before 18 months of age, a new study has revealed.

The research, led by Johns Hopkins scientists, has appeared in the April 21 issue of the Journal of the American Medical Association (JAMA).

The surgery involves placing a small electronic device into the ear that bypasses the inner ear”s damaged nerve cells and transmits sound signals to the brain.

The scientists followed 188 children, ages 6 months to 5 years, with profound hearing loss for three years after receiving cochlear implants at six U.S. hospitals.

They tracked the children”s newly emerging ability to recognize speech after the implant, and compared their levels of language development to those of 97 same-age children with normal hearing.

While speech and language skills improved in all children regardless of age after they received a cochlear implant, age emerged as a powerful predictor in just how much improvement was seen.

Lead investigator John Niparko, director of Otolaryngology – Head & Neck Surgery at Johns Hopkins, said: “We identified a clear pattern where implantation before 18 months of age conferred a much greater benefit than later implantation, allowing children to catch up fast, sometimes to nearly normal levels.

“Delaying intervention until a child loses every last bit of hearing deprives the brain of much-needed sound and speech stimulation that is needed to develop language.”

Each year of delay, the investigators say, can put a child a year behind in language development.

Therefore all young infants with suspected hearing loss, and those with family history, should be monitored vigilantly and referred for treatment immediately.

While the children in the study never reached the language levels of their hearing counterparts, those who received cochlear implants developed a decidedly better ability to understand and speak than they would have without the device, the researchers found.

When researchers looked at children of all ages, their ability to understand speech grew twice as fast as it would have been expected to without the device.

Their ability to communicate back, either with words or other age-appropriate modes of expression, grew nearly one and a half times faster than it would have without an implant.

Children who received a cochlear implant before age 18 months nearly caught up with their normal-hearing counterparts over the subsequent three years.

Children who received implants after age 3 had language gaps that corresponded directly to the length of delay before receiving the implant.

The study also showed that children implanted before age 18 months managed to reach speech and language developmental milestones much faster than those who received their implants later, revealing gaps between a child”s chronological and language ages.

Niparko said: “The impact of early cochlear implantation was greatly augmented in children whose caregivers use language to engage them.

“And we cannot overestimate the importance of caregiver communication with babies at a very early age, whether they have some degree of hearing loss or normal hearing.” (ANI)

Voice analysis could enable early detection of Parkinson’s disease

Washington, Apr 20 (ANI): Researchers at the University of Haifa have developed a new technique that could help in the early detection of Parkinson’s disease.

Developed by Prof. Shimon Sapir, the technique involves analysis of voice and articulation.

“This is a non-invasive, reliable and accurate technique that only requires the patient to read out a few simple sentences,” explained Sapir.

Parkinson’s is diagnosed when some 60 percent of the nerve cells in the area of the brain that controls motor activity are already damaged, which compromises the effectiveness of therapy and rehabilitation.

Sapir said that the muscles controlling voice and speech are also affected by the disease in most patients, and there is some evidence suggesting that speech abnormalities may antecede the classic symptoms of the disease.

He added that theoretically, an acoustic analysis of voice is sensitive enough to help detect subtle abnormalities in speech that are present in the early stages of the disease but are not perceptible to listeners.

“Statistically speaking, the existing acoustic tests did not pick up significant differences between speech articulation of individuals with early PD and the speech of healthy individuals, even when such differences were sometimes already noticeable to the listener,” Sapir pointed out.

He suggested that “this failure to detect acoustic differences has to do with the relatively large differences between speakers’ speech signals, which is mainly due to anatomical differences between speakers”.

The method developed by Sapir minimizes the effects of speaker variability and maximizes the sensitivity of the acoustic analysis to true differences between the speech of individuals with PD and that of healthy speakers.

Sapir and his colleagues tested the utility of the acoustic analysis method.

The results showed that the analysis system was sensitive to changes that occurred in those patients who had undergone therapy for speech.

The researchers indicated that the method not only enables early diagnosis of PD but also makes it possible to track changes in PD patients that may occur in response to treatment or as the disease progresses.

The results have been published in the Journal of Speech, Language, and Hearing Research. (ANI)

Gene that ties stress to obesity and diabetes identified

Washington, April 20 (ANI): Scientists have discovered a gene that ties stress to obesity and diabetes.

Dr. Alon Chen of the Weizmann Institute”s Neurobiology Department and his research team have now discovered that changes in the activity of a single gene in the brain not only cause mice to exhibit anxious behavior, but also lead to metabolic changes that cause the mice to develop symptoms associated with type 2 diabetes.

All of the body”s systems are involved in the stress response, which evolved to deal with threats and danger.

Behavioural changes tied to stress include heightened anxiety and concentration, while other changes in the body include heat-generation, changes the metabolism of various substances and even changes in food preferences.

The research team suspected that a protein known as Urocortin-3 (Ucn3) ties all of these things together. This protein is produced in certain brain cells – especially in times of stress – and it”s known to play a role in regulating the body”s stress response.

These nerve cells have extensions that act as ”highways” that speed Ucn3 on to two other sites in the brain: One, in the hypothalamus – the brain”s center for hormonal regulation of basic bodily functions – oversees, among other things, substance exchange and feelings of hunger and satiety; the other is involved in regulating behavior, including levels of anxiety.

Nerve cells in both these areas have special receptors for Ucn3 on their surfaces, and the protein binds to these receptors to initiate the stress response.

The researchers developed a new, finely-tuned method for influencing the activity of a single gene in one area in the brain, using it to increase the amounts of Ucn3 produced in just that location.

They found that heightened levels of the protein produced two different effects: The mice”s anxiety-related behavior increased, and their bodies underwent metabolic changes, as well.

With excess Ucn3, their bodies burned more sugar and fewer fatty acids, and their metabolic rate sped up.

These mice began to show signs of the first stages of type 2 diabetes: A drop in muscle sensitivity to insulin delayed sugar uptake by the cells, resulting in raised sugar levels in the blood. Their pancreas then produced extra insulin to make up for the perceived ”deficit.”

“We showed that the actions of single gene in just one part of the brain can have profound effects on the metabolism of the whole body,” Chen said.

These findings were published online this week in the Proceedings of the National Academy of Sciences (PNAS). (ANI)

Why some people are more susceptible to stress than others

Washington, March 31 (ANI): Scientists have found new clues to why some people are more susceptible to stress than others.

In a study of mice, researchers at UT Southwestern Medical Center determined that weeks after experiencing a stressful event, animals that were more susceptible to stress exhibited enhanced neurogenesis – the birth of new nerve cells in the brain.

Specifically, the cells that these animals produced after a stressful event survived longer than new brain cells produced by mice that were more resilient.

In addition, when researchers prevented neurogenesis in both stress-susceptible and resilient mice, the animals previously susceptible to stress became more resilient.

“This work shows that there is a period of time during which it may be possible to alter memories relevant to a social situation by manipulating adult-generated nerve cells in the brain,” said Dr. Amelia Eisch, associate professor of psychiatry at UT Southwestern and senior author of the study.

“This could eventually lead to a better understanding of why, in humans, there is an enormous variety of responses to stressful situations,” Eisch added.

The study appears in the Proceedings of the National Academy of Sciences. (ANI)

What are memories really made of

London, Mar 31 (ANI): Performing a study on sea slugs—organisms known for a relatively simple nervous system—researchers at the University of California, Los Angeles have shown what are memories really made of.

It is already known that memory formation involves the strengthening of synaptic connections between nerve cells.

Last year, a team led by Kelsey Martin, became the first to watch memories being made in sea slugs, in the form of new proteins appearing at the synapses.

They wanted to find where is knowledge stored in the complex brains of mammals.

Short-term memories, such as a telephone number about to be used, seem to be stored in two small curled-up structures called the hippocampi, buried deep in the brain”s two hemispheres.

In 2008 Courtney Miller and David Sweatt at the University of Alabama in Tuscaloosa showed in mice that during the first hour after a memorable event there were chemical changes to the DNA of neurons in this area, altering the proteins produced.

Over the subsequent week, there were similar changes to the genes of neurons in the cortex, reports New Scientist.

These changes seemed to be permanent, indicating that long-term memories are stored there.

The pair believes that they watched short-term memories form in the hippocampus, which then became long-term memories in the cortex.

The brain pays extra attention to things that frighten us, as remembering them could mean the difference between life and death.

A structure next to the hippocampus called the amygdala is known to play a role in stamping this indelible mark.

Last year, a team led by Sheena Josselyn at the Hospital for Sick Children in Toronto, Canada, found that in mice they could erase a frightening memory of a noise by killing amygdala neurons whose synapses had recently been strengthened after exposure to the noise.

It was the first time a specific memory had been traced to the nerve cells that encoded it. (ANI)

Blocking protein activity prevents Alzheimer”s-like memory loss in fruit flies

Washington, Mar 30 (ANI): Blocking the cellular signalling activity of a protein, called PI3 kinase, could prevent memory loss in fruit flies caused by brain plaques similar to those characteristic of Alzheimer”s disease in humans, according to a study.

Conducted by neuroscientists at Cold Spring Harbor Laboratory (CSHL), the study also resolves a long-standing controversy about the role of PI3 kinase, which was previously thought to have a protective function against the disease.

“Our work suggests that the peptides, or fragments, of ß-amyloid associated with Alzheimer”s disease directly increase the activity of PI3 kinase, which in turn causes memory loss and increases the accumulation of plaque in the brain,” explained Yi Zhong, who led the research team.

ß-amyloid peptides are known to alter a slew of cellular signalling proteins such as PI3 kinase, causing a wide range of cellular dysfunctions within the brain”s neurons, thus impairing brain activity.

The researchers conducted their study in a biological system that closely recapitulates the disease pathology seen in humans— fruit flies engineered to produce human ß-amyloid in their brains.

The team previously showed that these flies develop many key features of Alzheimer”s, including age-dependent memory loss, massive neurodegeneration, ß-amyloid deposits and plaque accumulation.

Searching for the molecular basis of memory loss, the team discovered the importance of PI3-kinase by studying a type of neurotransmission called long-term depression (LTD).

In LTD, nerve signal transmissions at particular synapses, or junctions between nerve cells, is depressed for an extended period, usually lasting hours.

LTD is known to be pathologically enhanced when ß-amyloid is present in fly brain.

The team has now found that LTD enhancement in the ß-amyloid-producing flies is due to increased activity of PI3-kinase.

A reduction of this activity via injections of PI3 kinase-blocking drugs or by switching off the gene that encodes PI3 kinase both restored normal LTD signals.

Using these measures, the team not only improved memory in aging fruit flies, but also decreased the buildup of ß-amyloid deposits.

The researchers also found that among patients, the disease is sometimes known as “brain diabetes” because brain tissue gradually becomes resistant to insulin, further impairing brain function.

“Our results now suggest that the Alzheimer”s brains might become insulin-resistant because PI3 kinase activity is already at the maximum due to its activation by ß-amyloid and therefore is no longer able to respond to insulin. It might be possible to tackle these various disease symptoms by targeting PI3 kinase,” explained Zhong.

The study appears online in the Proceedings of the National Academy of Sciences. (ANI)

Secrets behind sharp memory in ‘super-aged’ individuals revealed

Washington, Mar 24 (ANI): The secret behind the super-sharp memory in elderly people—the so-called “super-aged” individuals—has now been unveiled.

Dr. Changiz Geula, and colleagues said that the “super-aged” individuals, actually somehow escaped formation of brain “tangles”, which consist of an abnormal form of a protein called “tau” that damages and eventually kills nerve cells.

Named for their snarled, knotted appearance under a microscope, tangles increase with advancing age and peak in people with Alzheimer”s disease.

“This discovery is very exciting. It is the first study of its kind and its implications are vast. We always assumed that the accumulation of tangles is a progressive phenomenon throughout the normal aging process. Healthy people develop moderate numbers of tangles, with the most severe cases linked to Alzheimer”s disease. But now we have evidence that some individuals are immune to tangle formation. The evidence also supports the notion that the presence of tangles may influence cognitive performance. Individuals with the fewest tangles perform at superior levels. Those with more appear to be normal for their age,” said Geula.

The findings are based on examination of the nine brains from super-aged individuals.

Subjects who volunteer for this study get a battery of memory and other tests and agree to donate their brains for examination after death. They are considered ”super- aged” because of their high performance on the tests.

The tests include memory exercises to evaluate their ability to recall facts after being told a story or their ability to remember a list of more than a dozen words and recall those words sometime later.

Geula said the new study is unique in its focus on what”s right with the brains of older people.

It looks for insights into what lifestyle, genetic, or other factors may protect super-aged individuals from the age-related memory loss that affects most other people.

The scientists found that super-aged people appear to fall into two subgroups— Those who are almost immune to tangle formation and those that have few tangles.

“One group of super-aged seems to dodge tangle formation. Their brains are virtually clean, which doesn”t happen in normal-aged individuals. The other group seems to get tangles but it”s less than or equal to the amount in the normal elderly. But for some reason, they seem to be protected against its effects,” explained Geula.

He said that the next step involves determining why one subgroup is immune to tangle formation and the other seems to be immune to its effects. Environment, lifestyle, and genetics may be key factors.

“Ultimately, chemistry is one of the keys to understanding what makes these tangles form. By understanding the specific anatomic, pathological, genetic, and molecular characteristics of high-performing brains, we may eventually be able to protect normal brains from age-related memory loss,” said Geula.

The study was presented at the 239th National Meeting of the American Chemical Society (ACS). (ANI)

Songbirds offer insight into human speech production

Washington, March 19 (ANI): Scientists say they”re using songbirds to gain insight into how the human brain functions, which may lead to a better understanding of complex vocal behaviour, human speech production and ultimately, speech disorders and related diseases.

Pennsylvania State University Assistant Professors Dezhe Jin and Alexay Kozhevnikov said they are studying how songbirds transmit impulses through nerve cells in their brains to produce a complex behaviour, such as singing.

Songbirds, Jin said, are particularly well suited for studying speech production and syntax because there are more similarities between birdsong and human speech than one might think.

“We are not only interested in birds. We are ultimately interested in studying how the human brain works and better understanding ourselves,” Jin said.

He said songbirds are among the few that learn to communicate sounds in a manner similar to humans, with both the speech- and song-learning processes involving similar neural mechanisms.

Kozhevnikov and Jin said they record brain activity that occurs in songbirds during singing. In this way, the songbird”s brain acts as a laboratory for understanding neural networking.

The physicists said similarities between the neural networks in songbirds and humans makes them important for understanding the brain circuitry that underlies speech and language production.

The knowledge obtained from their research, they said, can function as a bridge to address and treat speech and language disorders.

The new research has been presented in Portland, Ore., during the March meeting of the American Physical Society. (ANI)

Snakes have ‘night vision’ to hunt for prey in the dark

London, March 15 (ANI): In a new research, scientists have discovered the receptors that allow snakes to find prey in the dark.

Vipers, pythons and boas have holes on their faces called pit organs, which contain a membrane that can detect infrared radiation from warm bodies up to one metre away.

At night, the pit organs allow snakes to ‘see’ an image of their predator or prey — as an infrared camera does — giving them a unique extra sense.

According to a report by Nature News, a study by US researchers, has now revealed how this works at a molecular level.

Nerve cells in the pit organ contain an ion channel called TRPA1 — an infrared receptor that detects infrared radiation as heat, rather than as light, thus confirming theories of pit-organ function long held by behavioural ecologists.

The receptors are also found inside the heads of mammals, where TRPA1 channels, also known as wasabi receptors, detect pungent irritants from mustard plants or other sources.

The pit organ contains nerve fibres known as trigeminal ganglia.

The researchers reasoned that a good way to home in on the organ””s molecular heat detectors would be to compare the trigeminal ganglia with the dorsal root ganglia.

The latter supply the brain with sensory input from the neck down and would be less likely to produce proteins that only pit-organs need to detect heat.

The team looked at the different RNAs produced by each type of nerve — an indication of which genes are active and producing proteins.

They found only one, TRPA1, which was being expressed differently in the two types of ganglia, with the gene in the trigeminal ganglia producing 400 times more RNA than that in the dorsal root ganglia.

According to the team’s observations, rattlesnake TRPA1 is activated by temperatures higher than about 28 degree Celsius — roughly the temperature a snake would ‘feel’ from a mouse or a squirrel about a metre away.

“Although aspects of the findings contradict known behavioural and physiological work, the use of molecular genetic techniques is a new step in understanding how the facial pits work,” said herpetologist Aaron Krochmal from Washington College in Chestertown, Maryland. (ANI)

Scientists unveil antioxidant that controls spinal cord development

Washington, September 19 (ANI): John Hopkins scientists have gained significant insights into a mechanism whereby an antioxidant protein controls the activity of another protein, critical for the development of spinal cord neurons.

Writing about their work in the journal Cell, the researchers have said that it describes a never-before known mechanism of protein control.

“This is the first time we’ve seen this type of chemical reaction control neuronal differentiation. And it’s probably not specific for motor neurons that we study, but also for development of a wide variety of neurons,” says Dr. Shanthini Sockanathan, an associate professor at the Johns Hopkins Solomon H. Snyder Department of Neuroscience.

Studies conducted in the past have already shown that the GDE2 protein can cause immature cells in the spinal cord to differentiate into motor neurons, the nerve cells that connect to and control muscle contraction.

Too little GDE2 causes motor neurons to not develop, while too much GDE2 causes them to develop too quickly, depleting progenitor pools.

“We reasoned that there must be tight control of GDE2 so we set out to look for the regulator by looking for other proteins that can bind to GDE2,” says Sockanathan.

In the current study, the researchers used biochemical approaches to isolate all proteins that normally bind to GDE2 in the developing spinal cord, and then conducted proteomic analysis to identify all binding proteins.

Their effort led to the identification of a few hundred proteins.

One protein, known as Prdx1, had been reported by others to have tumour-suppressing abilities, which caught Sockanathan’s eye for further investigation.

The researchers first asked whether the Prdx1 protein could affect motor neuron development by removing it from developing spinal cords of chick embryos.

They observed that embryos lacking Prdx1 showed loss of motor neurons similar to that seen in embryos lacking GDE2, suggesting that indeed Prdx1 is somehow involved in motor neuron development.

In a bid to determine how Prdx1 and GDE2 interact to cause immature cells to develop into motor neurons, the researchers induced mutations in the proteins, and then examined how they would affect the cells.

They found that mutations that prevent the two proteins from binding resulted in no motor neurons.

Mutations that disrupt the enzyme abilities of GDE2 and Prdx1 also resulted in no motor neurons, said the researchers.

In fact, only when GDE2 and Prdx1 can bind each other and work as enzymes do motor -neurons develop.

“So we thought maybe the antioxidant enzyme activity of Prdx1 is doing something to regulate GDE2 function,” says Sockanathan.

Her team also observed that bacteria and yeast versions of Prdx1 are able to help alter certain chemical bonds in proteins that form between specific amino acids that contain so-called sulfhydryl (-SH) groups, something that led them to re-examine the GDE2 protein for these groups.

As it turns out, they found 4 in GDE2: Three are close together and one is clear on the other end of the protein.

They first performed some biochemistry experiments to determine whether these sulfhydryl groups can form disulfide bonds-they can. Then, two at a time, the researchers engineered mutations to replace each -SH-containing amino acid in GDE2, and asked whether the mutated protein could still bind to Prx1.

They found one combination of mutations that did not behave the same as the unmutated control, leading them to conclude that Prx1 must break the chemical bond between those two specific amino acids.

“We think that Prx1 breaks this bond in GDE2, activating it to promote motor neuron differentiation. This suggests a new general control mechanism that regulates when cells divide and when they differentiate. We’re excited to see how widespread it might be,” says Sockanathan. (ANI)

New Alzheimer’s-related genes identified

London, Sept 7 (ANI): A group of British scientists have identified two new genes that are linked with Alzheimer’s disease.

After analysing the gene pool of more than 19,000 older European and U.S. residents, researchers from the School of Medicine at Cardiff in the UK and Washington University School of Medicine in St. Louis have discovered the genes APOJ, also known as clustrin, on chromosome 8, and PICALM, on chromosome 11.

A team of French colleagues have also uncovered a third gene called APOE4, the only one previously linked to the more common late-onset form of the disease.

“There’s good evidence that these new genes may be novel risk factors, the first discovered since APOE in 1993,” Nature magazine quoted Washington University researcher and co-author Alison M. Goate as saying.

“So it’s a very important observation because this study is the first to provide such significant evidence of novel genetic risk factors for the most common form of Alzheimer’s disease,” she added.

Co-author Dr. John C. Morris, of Washington University, said: “The power of the new Genome Wide Association Study methods is that with large datasets we can now identify genes that earlier techniques were unable to confirm. These new genes associated with Alzheimer’s disease provide new clues about how the illness develops.”

Prof Julie Williams, Chief Scientific Adviser to the Alzheimer’s Research Trust, said: “Both CLU and PICALM highlight new pathways that lead to Alzheimer’s disease. The CLU gene produces clusterin which normally acts to protect the brain in a variety of ways. Variation in this gene could remove this protection and contribute to Alzheimer’s development.”

She added: “PICALM is important at synapses – connections between brain cells – and is involved in the transport of molecules into and inside of nerve cells, helping form memories and other brain functions.

We know that the health of synapses is closely related to memory performance in Alzheimer’s disease, thus changes in genes which affect synapses are likely to have a direct effect on disease development.”

Goate believes that many more genes may be involved in Alzheimer’s risk.

A research article on the study has been published in the journal Nature Genetics. (ANI)